Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no other substantive content changes detected.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as expanded information on various eye diseases and conditions. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.